Insulet Corporation Announces CFO Transition and Third Quarter Revenue Outlook

Insulet Corporation announced the appointment of Flavia H. Pease as the new Executive Vice President and Chief Financial Officer, effective September 30, 2025. Pease will succeed Ana M. Chadwick, who will transition to a Senior Advisor role to ensure a smooth handover. Pease brings extensive experience from her roles at Charles River Laboratories and Johnson & Johnson. The company also expects to exceed its previously issued third quarter 2025 total revenue growth guidance, driven by strong new customer starts in both U.S. and international markets. Pease's compensation includes a prorated annual equity award, a sign-on equity award, and a cash sign-on bonus. The transition is not related to any disagreements with the company on accounting practices, financial statements, internal controls, or operations.